Please login to the form below

Not currently logged in
Email:
Password:

Seres

This page shows the latest Seres news and features for those working in and with pharma, biotech and healthcare.

Microbiome specialist Rebiotix chalks up C. diff trial success

Microbiome specialist Rebiotix chalks up C. diff trial success

Seres that is spearheading a push into pharma.

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Each target could accrue $80m in milestone payments. Continuing to build on its interests in pharma, Nestlé put in place a $1.9bn headline deal with Seres Therapeutics. ... 32, 000. Seres Therapeutics/ Nestle Health Science. Collaboration. Rights to

  • A patient's eye view of the digital doctor A patient's eye view of the digital doctor

    Somebody who understands this better than most is Michael Seres, an evangelising ePatient passionate about the ability of new technologies and social media to help him, his condition and his

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Turnstone Biologics bolsters leadership team Turnstone Biologics bolsters leadership team

    Otero joins from Seres Therapeutics, where he was vice president of bioprocess development and manufacturing. ... Prior to his role at Seres, Otero served Merck &Co as its director of engineering.

  • Former Merck & Co exec to lead Seres Former Merck & Co exec to lead Seres

    Roger Pomerantz was senior VP at pharma giant. Seres has appointed Dr Roger Pomerantz, formerly a senior figure at Merck &Co, to lead the company as CEO and chairman. ... This included external research and academic alliances. He will now lead a company

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics